Antimicrobial Resistance in Staphylococcus

Staphylococcus aureus is a common bacterium that, in its methicillin-resistant form (MRSA), defeats the antibiotics most routinely used to treat bacterial infections, making even ordinary skin infections or surgical wounds potentially life-threatening. Researchers study how the organism acquires and spreads resistance genes, how its virulence factors—toxins and surface proteins—help it evade the immune system, and how infection patterns differ between hospitals and the wider community. A pressing concern is the emergence of strains with reduced susceptibility to vancomycin, currently one of the few reliable last-resort treatments, which threatens to leave clinicians with no dependable options. Active work focuses on identifying new drug targets through genetic analysis, improving surveillance to track resistant strains as they spread across populations, and refining clinical protocols to reduce both mortality and the unnecessary antibiotic use that accelerates resistance in the first place.

Works

123,516

Total citations

2,052,833

Keywords

MRSAStaphylococcus aureusAntimicrobial ResistanceEpidemiologyClinical ManagementVirulence Factors